Participant Opinion:
Yvonne Gilleece, MD, Brighton and Sussex University Hospitals, UK. Participant at the Dublin course (4 September) stated: 'The best educational course I have attended for some time! Many thanks to all the speakers'.
CCR5 course
With the registration of the first oral Entry Inhibitor, Maraviroc (Celsentry) treatment strategies may change in the coming years. For this reason Virology Education is organizing the following course:
How to use CCR5 antagonists in clinical practice
Seven countries
These courses will be held in seven different European countries attended by participants from fifteen different countries. The official language will be English.
CME accrediattion
We have applied for CME accreditation. This program is made possible with an unrestricted educational grant by Pfizer.
Participant opinion:
Nicky Mackie, MD, Imperial College Healthcare NHS Trust, London. Participant at the Dublin course (4 September) stated: 'Really informative, enjoyable and the most useful meeting in a long time!'
Countries & Dates
UK & Ireland, 4 September
Italy, 6 October
Germany, Austria & Switzerland, 7 October
The Netherlands, Belgium & Luxembourg, 17 December
France, 18 December
Spain, 19 December
The program
CCR5 clinical trial data
Tropism and tropism testing
Resistance among NRTI, NNRTI, PI, and Integrase inhibitors
Drug-drug interactions with CCR5 inhibitors
Presentation of clinical cases
More Information?
If you would like to have more information on these courses please contact Jo-Els avn der wouder, Senior Event Manager Virology Education:
jo-els.vanderwoude@vironet.com
